National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 2) – specification under subsection 84AAA(2) (PB 17 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00206

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 17 of 2015
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 2) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 23rd February 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 2) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 17 of 2015.
 
2          Commencement
 
This Instrument commences on 1 March 2015.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
 
Schedule 1        Amendments
 
[1]           Schedule 1, after entry for Apixaban in the form Tablet 5 mg
insert:
Aripiprazole
Powder for injection 300 mg (as monohydrate) with diluent
Injection
1
5
 

 
Powder for injection 400 mg (as monohydrate) with diluent
Injection
1
5